LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 29.86 | 21.74 | 2542 | 1887 | 1.3471 | 1.0947 | MN20160310_N01 | K18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 31.83 | 21.74 | 1903 | 2110 | 0.9019 | 0.9690 | MN20160310_N01 | D09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 31.83 | 21.74 | 1994 | 2110 | 0.9450 | 0.9829 | MN20160310_N01 | D09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 31.83 | 21.74 | 16 | 2110 | 0.0076 | -0.0454 | MN20160310_N01 | K18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 31.83 | 21.74 | 2817 | 2110 | 1.3351 | 1.0895 | MN20160310_N01 | K18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 33.80 | 21.74 | 2167 | 2381 | 0.9099 | 0.9723 | MN20160310_N01 | D09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 33.80 | 21.74 | 2258 | 2381 | 0.9481 | 0.9843 | MN20160310_N01 | D09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 33.80 | 21.74 | 62 | 2381 | 0.0260 | 0.1673 | MN20160310_N01 | K18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 33.80 | 21.74 | 3126 | 2381 | 1.3126 | 1.0819 | MN20160310_N01 | K18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 35.77 | 21.74 | 2394 | 2602 | 0.9198 | 0.9759 | MN20160310_N01 | D09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 35.77 | 21.74 | 2491 | 2602 | 0.9570 | 0.9873 | MN20160310_N01 | D09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 35.77 | 21.74 | 25 | 2602 | 0.0096 | 0.0204 | MN20160310_N01 | K18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 35.77 | 21.74 | 3362 | 2602 | 1.2917 | 1.0755 | MN20160310_N01 | K18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 37.74 | 21.74 | 2648 | 2828 | 0.9362 | 0.9813 | MN20160310_N01 | D09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 37.74 | 21.74 | 2716 | 2828 | 0.9603 | 0.9885 | MN20160310_N01 | D09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 37.74 | 21.74 | 30 | 2828 | 0.0106 | 0.0469 | MN20160310_N01 | K18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 37.74 | 21.74 | 3525 | 2828 | 1.2463 | 1.0637 | MN20160310_N01 | K18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 39.71 | 21.74 | 2799 | 3084 | 0.9076 | 0.9730 | MN20160310_N01 | D09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 39.71 | 21.74 | 2895 | 3084 | 0.9387 | 0.9824 | MN20160310_N01 | D09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 39.71 | 21.74 | 23 | 3084 | 0.0075 | 0.0079 | MN20160310_N01 | K18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 39.71 | 21.74 | 3878 | 3084 | 1.2574 | 1.0651 | MN20160310_N01 | K18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 41.68 | 21.74 | 2997 | 3418 | 0.8766 | 0.9642 | MN20160310_N01 | D09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 41.68 | 21.74 | 3100 | 3418 | 0.9068 | 0.9734 | MN20160310_N01 | D09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 41.68 | 21.74 | 66 | 3418 | 0.0193 | 0.1644 | MN20160310_N01 | K18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 41.68 | 21.74 | 4327 | 3418 | 1.2657 | 1.0656 | MN20160310_N01 | K18 |